跳至主要内容
临床试验/NL-OMON32247
NL-OMON32247
已完成
不适用

High-field magnetic resonance imaging in multiple sclerosis - High field MRI in MS

Vrije Universiteit Medisch Centrum0 个研究点目标入组 120 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
MS
发起方
Vrije Universiteit Medisch Centrum
入组人数
120
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Observational non invasive

研究者

入排标准

入选标准

  • clinical definite MS, age 18\-60 years, EDSS \< 5\.5, able to be scanned at least 2 times.

排除标准

  • Clinically isolated syndrome
  • Other neurological disorders
  • Claustrophobia
  • Foreign non MR compatible metal objects in the body
  • Foreign metal objects in or close to the head

结局指标

主要结局

未指定

相似试验

已完成
不适用
DOUBLE BLIND RANDOMIZED MULTICENTRIC PARALLEL GROUP STUDY TO COMPARE MONTELUKAST WITH PLACEBO IN PEDIATRIC PATIENTS OF 6 TO 24 MONTHS OF AGE WHO HAVE ASTHMA-J458 Mixed asthmaMixed asthmaJ458
PER-046-00MERCK SHARP & DOHME PERU S.R.L.,
进行中(未招募)
不适用
MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY ON THE THERAPEUTIC EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE SUSPENSION FOR INHALATION 800 micrograms TWICE DAILY VS PLACEBO ADDED TO ANTIBIOTIC THERAPY IN PATIENTS WITH ACUTE RHINOSINUSITISAcute rhinosinusitisMedDRA version: 14.1Level: LLTClassification code 10052106Term: RhinosinusitisSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2011-001459-35-ITCHIESI
尚未招募
不适用
Development of real time PCR based detection method for meningitisHealth Condition 1: B998- Other infectious disease
CTRI/2022/07/043906Science and Engineering Research Board GOI
招募中
不适用
Combined diffusion tensor imaging (DTI, global fiber tracking and voxel based morphometry (VBM) in patients with idiopathic or atypical Parkinson syndromeG20G23Parkinson diseaseOther degenerative diseases of basal ganglia
DRKS00003454eurologische Universitätsklinikum Freiburg200
已完成
不适用
MULTICENTRIC DOUBLE-BLIND RANDOMIZED PARALLEL GROUPS CONTROLLED WITH PLACEBO STUDY WHOSE PURPOSE IS TO EVALUATE THE EFFECTIVENESS SAFETY AND TOLERABILITY OF F-1394 IN COMBINATION WITH THE REDUCTASE INHIBITOR HMG-COA SIMVASTATIN IN THE ALTERATION OF LIPIDS
PER-058-00MERCK SHARP & DOHME PERU S.R.L.,